Global Molecular Quality Controls Market 2020: Rising Demand for Multi-Analyte Controls
Market Drivers & Challenges: Increasing Number of Accredited Clinical Laboratories, Growing Adoption of Third-Party Quality Controls, Rising Demand for External Quality Assessment Support, Lack of Mandatory Regulations for Clinical Laboratory Accreditation in Several Emerging Countries, Complex Regulatory Frameworks
Get Free PDF Sample Brochure @ https://decisionmarketreports.com/request-sample/1075430
Global molecular quality control market is valued at approximately USD 119.8 million in 2017 and is anticipated to grow with a healthy growth rate of more than 10.2 % over the forecast period 2018-2025. Rising demand for external quality assessment and growing number of accredited clinical laboratories are some trends triggering the growth of the Molecular Quality Controls market over the forecast period. Global molecular quality control market is significantly driven by government investments to promote clinical research. The U.S. Food and Drug Administration announced that it has awarded 15 new clinical trial research grants totaling more than $22 million over the next four years to boost the development of products for patients with rare diseases. These new grants were awarded to principal investigators from academia and industry across the country. As a result, the demand for molecular quality controls products would increase as these products are widely used to authenticate the accurate treatments of target disease owing to the rising awareness about health concerns, promoting the growth of the market across the globe over the forecast period. Furthermore, growing demand for multi-analyte controls offers lucrative growth prospects for the molecular quality controls market. However, high cost associated with quality control is expected to hinder the growth of the market during the forecast period.
On the basis of segmentation, the molecular quality controls market is segmented into product, analyte type, application, and end-user. The product segment of global molecular quality control market is classified into independent controls and instrument-specific controls. On the basis of the application segment, the market is diversified into infectious diseases, oncology, genetic testing and other applications of which oncology segment is expected to emerge as the fastest-growing segment owing to the increasing research on cancer biomarkers, rising prevalence of cancer and growing focus on personalized medicine. The analyte segment includes single-analyte controls and multi-analyte controls of which multi-analyte controls is expected to emerge as the fastest-growing segment due to increasing preference for multi-analyte controls for clinical as well as research applications due to the benefits associated with its use, such as time savings, cost-effectiveness and the availability of a wide range of formats that enhance flexibility for users. On the basis of the end-user segment, the molecular quality controls market is diversified into clinical laboratories, hospitals, IVD manufacturers and contract research organizations, academic & research institutes and other end users.
Know more about research methodology @ https://decisionmarketreports.com/request-methodolgy/1075430
The regional analysis of the molecular quality controls market is considered for the key regions such as North America, Europe, Asia Pacific, Latin America, and ROW. North America holds the leading position in molecular quality controls market owing to the well-established healthcare sector both in U.S and Canada, easy accessibility to technologically advanced products and presence of the large number of leading molecular quality control products manufacturers. Whereas, Asia-Pacific is expected to emerge as the fastest-growing region in terms of market share. The growth of Asia-Pacific is witnessed owing to high demand for the accurate and high-quality diagnostics tests from large patient population.
The leading market players mainly include-
o Seracare Life Sciences Inc.
o Thermo Fisher Scientific
o Bio-Rad Laboratories
o Microbiologics Inc.
o Roche Diagnostics
o Abbott Laboratories
o Maine Molecular Quality Controls Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
o Independent Controls o Instrument-Specific Controls o PCR o DNA Sequencing & NGS o Other Technologies
By Analyte Type:
o Single-Analyte Controls o Multi-Analyte Controls
o Infectious Diseases o Oncology o Genetic Testing o Other Applications
o Clinical Laboratories
o IVD manufacturers and Contract Research Organizations
o Academic & Research Institutes
o Other End Users
Decision Market Reports is a one-stop solution, covers market research studies of all the industries, companies and regions. DMR aims at providing quality research, and insights about every market to helps our clients in taking right decisions. Our repository consists of most trending industry reports, niche areas, and leading company profiles. A comprehensive collection of reports is updated daily to offer hassle-free access to our latest updated report databases.
304, S Jones Blvd,
NV 89107, USA
US Toll Free +18666051052